18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms

Not yet recruitingOBSERVATIONAL

Enrollment

152

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

June 3, 2027

Study Completion Date

December 31, 2027

Conditions

Neuroendocrine Tumors

Interventions

DIAGNOSTIC_TEST

18F-AlF-NOTA-Octreotide PET-CT or PET-MR

18F-Octreotide PET/CT or PET/MR And enhanced CT or MR Imaging

All Listed Sponsors

lead

First Affiliated Hospital of Zhejiang University

OTHER

NCT07102056 - 18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms | Biotech Hunter | Biotech Hunter